In addition, Galectin-1 increased AXL receptor tyrosine kinase (AXL) and proto-oncogene receptor tyrosine kinase (MET) phosphorylation, which induced sorafenib resistance and affected sorafenib-mediated ferroptosis in HCC cells. The gene discussed is AXL; the disease is hepatocellular carcinoma.